Kohtaro Hirao, Hersa Milawati, Kentaro Yamada, Chio Kobayashi, Yuta Maki, Yasuhiro Kajihara
Protein glycosylation crucially regulates the function and stability of mammalian membrane and secreted proteins. However, because biological glycan processing is inherently a non-template-driven process, natural glycoproteins exist as heterogeneous mixtures. This structural heterogeneity has historically hindered the precise study of specific glycoforms. To overcome this fundamental limitation, advanced chemical and semi-synthetic strategies have emerged, now enabling the precise construction of structurally homogeneous glycoproteins. In this review, we highlight recent progress in the chemical and semi-synthetic assembly of these pure glycoforms, with a focus on advanced peptide ligation technologies. Ultimately, by securing scalable access to well-defined synthetic models, these precision techniques are uncovering latent physiological functions and laying the groundwork for novel, highly targeted therapeutics.